[Form 4] BKV Corporation Insider Trading Activity

Rhea-AI Filing Summary

BKV Corp insider filing reports that Lindsay B. Larrick, Chief Legal and Administrative Officer, sold 9,187 shares of common stock on 09/02/2025 under a Rule 10b5-1 plan. The weighted-average sale price was $23.1832, with individual sale prices ranging from $22.915 to $23.285. After the reported transactions, the reporting person beneficially owned 191,341 shares. The filing was submitted by an attorney-in-fact and discloses the 10b5-1 plan adoption date of November 22, 2024.

Positive

• Transaction executed under a Rule 10b5-1 plan, indicating the sale was pre-planned and intended to provide an affirmative defense to insider trading claims
• Complete price disclosure including weighted-average price and the reported price range ($22.915–$23.285)
• Post-transaction beneficial ownership disclosed (191,341 shares), giving clear context on remaining insider stake

Negative

• Officer reduced holdings by 9,187 shares, which is a decrease in insider ownership
• No explanation provided in the filing for the economic rationale of the sale beyond the 10b5-1 plan reference

Insights

Securities Compliance Analyst

TL;DR: Routine, pre-planned insider sale executed under a 10b5-1 plan; no new compensatory grants or derivative activity reported.

The Form 4 documents a sale of 9,187 common shares by the Chief Legal and Administrative Officer executed on 09/02/2025 pursuant to a Rule 10b5-1 trading plan adopted 11/22/2024. The filing discloses a weighted-average sale price of $23.1832 with transaction prices ranging $22.915–$23.285, and post-transaction beneficial ownership of 191,341 shares. Because the sale is under a 10b5-1 plan and was reported promptly, this appears to be a compliance-driven, pre-arranged disposition rather than an opportunistic trade.

Corporate Governance Specialist

TL;DR: Governance signal: officer reduced holdings through pre-established plan; filing contains full price range and plan date.

The disclosure includes key governance details: the relationship of the reporting person (officer), adoption date of the 10b5-1 plan, and a commitment to provide lot-level sale information on request. There are no reported acquisitions, option exercises, or derivative transactions. From a governance perspective, the filing meets standard disclosure expectations for an insider sale executed under a written plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Larrick Lindsay B

(Last) (First) (Middle)

1200 17TH STREET, SUITE 2100

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BKV Corp [ BKV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal and Admin Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2025		S(1)		9,187	D	$23.1832(2)	191,341	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2024.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.915 to $23.285, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Kathleen Lenox, attorney-in-fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did BKV insider Lindsay B. Larrick sell according to the Form 4?

The filing shows a sale of 9,187 shares of BKV common stock executed on 09/02/2025.

At what price were the BKV shares sold in the Form 4?

The weighted-average sale price was $23.1832; individual trade prices ranged from $22.915 to $23.285.

Was the sale made under a trading plan for BKV (10b5-1)?

Yes. The Form 4 states the transaction was effected pursuant to a Rule 10b5-1 plan adopted on 11/22/2024.

How many BKV shares does the reporting person own after the sale?

After the reported transactions the reporting person beneficially owned 191,341 shares.

Who signed the Form 4 filing for BKV's insider transaction?

The Form 4 was signed by Kathleen Lenox, attorney-in-fact, on 09/02/2025.